We hear a lot about vaccines, but how do we know they’re working? In the latest LabMind podcast episode, Dr. Patricia Slev explains how lab testing helps us understand the body’s immune response. Listen here: https://t.co/qXks3TeeUB
Our latest white paper dives into the benefits and drawbacks of lab test insourcing and illustrates how ARUP provides expert guidance and data-driven insights to empower labs to make strategic insourcing decisions and keep care closer to home. https://t.co/13b34qL6Oj
Laboratory testing for myasthenia gravis (MG) can inform prognosis and therapeutic decision-making. Visit the newly updated ARUP Consult topic for a discussion of lab tests used in the diagnosis of MG: https://t.co/LN3ZjStm1K
June marks Pride Month—a time to acknowledge the LGBTQIA+ community and reflect on the importance of inclusion and respect. The Pride Employee Engagement Group offers a variety of resources to ARUP employees.
Explore the potential role for genomic analysis in the categorization of poorly differentiated primary liver carcinomas (PD-PLCs), along with insights gained from next generation sequencing of both PD-PLCs and combined hepatocellular cholangiocarcinomas. https://t.co/ohqot8sukF
Happening today! After this webinar you will be able to formulate a differential diagnosis and recognize age-specific clinical and #laboratory clues that guide the initial evaluation of #anemia in #pediatric populations. https://t.co/hIM2keFf8B
Lab testing plays an important role in the diagnostic workup of interstitial lung diseases, helping to identify potential autoimmune, environmental, infectious, and genetic causes. Visit the updated ARUP Consult topic for more info: https://t.co/r9iKCcxa9S
Today we remember and honor those who have made sacrifices in service of our country. We’re grateful for their courage and dedication, and we want to express our gratitude for the veterans who continue to serve our communities every day.
Our newborn drug detection panels detect a range of substances. ARUP analyzes specimens by mass spectrometry up front, providing specific, accurate results initially and eliminating unnecessary testing. Learn more about ARUP’s approach: https://t.co/aKtMmHjHYo
Test your parasite identification skills with this photo quiz published in the Journal of Clinical Microbiology. ARUP parasitologists discuss why expertise in parasitology is still critical for accurate diagnosis in the era of artificial intelligence. https://t.co/xemxpGDjyM
ARUP is proud to support the Stark Science Learning Center Gala, advancing science education and inspiring future innovators.
Learn more: https://t.co/miaxF106M2
#STEMeducation
ARUP Healthcare Advisory Services brings extensive experience in advanced clinical laboratory analytics to help you hone a razor-sharp business strategy to eliminate waste, reduce costs, and improve patient care.
Schedule a consultation today: https://t.co/SdX90sxu8t
Join this webinar as Archana Agarwal, MD, covers identifying uncommon causes of #anemia, including hereditary hemolytic anemias and hereditary bone marrow failure syndromes. Learn how to select appropriate screening and confirmatory tests. Register now: https://t.co/hIM2keFf8B
Monica Theriot, MLS(ASCP)CMCGMC, lab supervisor for the Cytogenetics Laboratory at ARUP, presented yesterday at the American Cytogenomics Conference.
Hear from Katie Rudd, PhD, FACMG, ARUP medical director of Cytogenetics and Genomic Microarray, at 9 a.m.
ARUP medical directors are at the American Cytogenomics Conference.
Join Monica Theriot, MLS(ASCP)CMCGMC at 5:15 p.m.for Three Pediatric Cases of B-Cell Acute Lymphoblastic Leukemia That Challenged Conventional Assumptions.
Join ARUP Medical Director Katie Rudd, PhD, FACMG, for her presentation on the diagnostic culprits of atypical cell-free DNA screens. The presentation will be held on Tuesday, May 19, at 9:00 a.m.
Don’t miss this presentation, Three Pediatric Cases of B-Cell Acute Lymphoblastic Leukemia That Challenged Conventional Assumptions, by Monica Theriot, MLS(ASCP)CMCGCM. Her presentation will be held on Monday, May 18, at 5:15 p.m.
Jan Verheijen, PhD, will discuss pediatric cases of B-cell acute lymphoblastic leukemia. His presentation, Cytogenetic Characterization of Incipient B-ALL With High Hyperdiploidy in Two Pediatric Cases, will be on Monday, May 18, 2026, at 4:45 p.m. Don’t miss it!